Related Experiment Video
Updated: Aug 11, 2025
08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.1K
JAK inhibitors in rheumatology
1Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan.
Immunological Medicine
|February 6, 2023
Summary
Janus kinase inhibitors (JAKis) offer a novel therapeutic approach for inflammatory diseases, showing efficacy comparable to biologics in rheumatology. Future applications for JAK inhibitors extend to rare immune-mediated conditions.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Background:
- Janus kinase (JAK) inhibitors represent a distinct drug class compared to biologics.
- JAK proteins are crucial intracellular signaling mediators activated by cytokines and hormones in inflammatory pathways.
- JAK expression is implicated in diverse immune-mediated inflammatory diseases.
Purpose of the Study:
- To review the current efficacy and safety of Janus kinase inhibitors (JAKis) in treating rheumatic diseases.
- To explore the potential future clinical applications of JAKis, including for rare diseases.
Main Methods:
- Review of current clinical trial data and literature on JAK inhibitors in rheumatology.
- Analysis of therapeutic efficacy and safety profiles of JAKis compared to existing treatments.
- Exploration of JAKis' role in immune-mediated inflammatory diseases.
Main Results:
- JAK inhibitors demonstrate therapeutic efficacy comparable to biologics in various rheumatic conditions.
- JAKis are rapidly adopted in rheumatology due to their unique mechanism of action.
- Ongoing clinical trials are evaluating JAKis for multiple rheumatic diseases.
Conclusions:
- Janus kinase inhibitors are a promising therapeutic option for rheumatic diseases, offering an alternative to biologics.
- The utility of JAK inhibitors extends to a broad spectrum of immune-mediated inflammatory diseases.
- Further research into JAK inhibitors may unlock new treatments for rare diseases.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
728
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
728
01:23Rheumatic Heart Disease I: Introduction
27
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
27
01:21Rheumatic Heart Disease III: Medical Management
24
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
24
01:29Inflammatory Bowel Disease IV: Pharmacological Management
169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
169
01:20Rheumatic Heart Disease IV: Nursing Management
30
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
30
01:20The JAK-STAT Signaling Pathway
9.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.1K